Although no mutually exclusive mutation pairs were identified, prior studies in RCC have reported recurrent alterations in TP53 and PTEN, with chRCC exhibiting particularly high mutation rates in both genes [5,19,20,31]. Here, PTEN is linked to renal cell carcinoma.